行情

CSII

CSII

心血管系统公司
NASDAQ

实时行情|Nasdaq Last Sale

42.48
-1.46
-3.32%
已收盘, 16:32 11/13 EST
开盘
43.69
昨收
43.94
最高
43.92
最低
42.27
成交量
18.59万
成交额
--
52周最高
52.54
52周最低
24.84
市值
14.95亿
市盈率(TTM)
-456.2836
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CSII 新闻

  • 新浪发布2019年第三季度未经审计财报
  • 新浪科技.3小时前
  • 新浪三季度调整后每股收益超预期
  • 新浪财经.3小时前
  • 张朝阳:搜狐将在娱乐游戏方面发力应对经济周期
  • TechWeb.3小时前
  • 菲律宾央行暂停降息,但宽松周期并未结束
  • 环球外汇网官网.3小时前

更多

所属板块

医疗设备、用品及经销
+0.36%
医疗设备和用品
+0.49%

热门股票

名称
价格
涨跌幅

CSII 简况

Cardiovascular Systems, Inc. is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral. The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries.
展开

Webull提供Cardiovascular Systems Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。